Concepedia

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study

Werner Hacke, Anthony J. Furlan, Yasir Al‐Rawi, Antoni Dávalos, Jochen B. Fiebach, Franz Gruber, Markku Kaste, Leslie Lipka, Salvador Pedraza, Peter A. Ringleb,

The Lancet Neurology · 2008 · 569 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group · New England Journal of Medicine · 1995 · 11.7K citations

, , +17

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

, , +11

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Werner Hacke, Markku Kaste, Cesare Fieschi et al. · The Lancet · 1998 · 3.7K citations

, , +12

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Hiltrud S. Mueller, A. R. DYER, Mark A. Greenberg · 1985 · 3.6K citations

, , +11

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Werner Hacke · JAMA · 1995 · 2.9K citations

, , +17